Literature DB >> 8863684

Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors.

B Schnyder1, S M Lugli, S Schnyder-Candrian, V M Eng, R Moser, J Banchereau, B Ryffel, B D Car.   

Abstract

The distribution of the interleukin (IL)-4 receptor in normal human and common marmoset (Callithrix jacchus) tissues was examined by immunofluorescence and flow cytometry using monoclonal antibodies specific for the human IL-4 receptor to gain further insight into IL-4-mediated inflammatory and immunological events. IL-4 receptor positivity was unequivocally demonstrated on lymphocytes, predominantly T cells, and on blood vessels in many tissues. Vascular IL-4 receptor immunofluorescence consisted of a strong smooth muscle cell positivity and weaker positive staining of capillary and venular endothelial cells. Subnanomolar concentrations of IL-4 induced a genistein-sensitive up-regulation of VCAM-1 in vascular cell cultures. Tumor necrosis factor-alpha induced a genistein-resistant up-regulation of VCAM-1. IL-4 strongly induced expression of the IL-4 receptor on splenocytes (T lymphocytes) but not on vascular smooth muscle or endothelial cell cultures. Receptor cross-linking to [125I]IL-4 revealed a 65- to 75-kDa accessory receptor subunit consistent with a recently cloned IL-13 receptor associated with the IL-4 receptor on both vascular endothelial and smooth muscle cells. The demonstration of a vascular distribution pattern for the IL-4 receptor in addition to expression on lymphocytes suggests that vascular functional alterations, transduced through a unique IL-4 receptor complex (the type II IL-4 receptor), may be of importance during immunological and allergic inflammatory events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863684      PMCID: PMC1865187     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood.

Authors:  N Ishii; T Takeshita; Y Kimura; K Tada; M Kondo; M Nakamura; K Sugamura
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

2.  An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.

Authors:  R I Tepper; R L Coffman; P Leder
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

3.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

4.  Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production.

Authors:  T Yoshimoto; A Bendelac; C Watson; J Hu-Li; W E Paul
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

5.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.

Authors:  A D Keegan; K Nelms; M White; L M Wang; J H Pierce; W E Paul
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

6.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

7.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

8.  Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes.

Authors:  S Schnyder-Candrian; R M Strieter; S L Kunkel; A Walz
Journal:  J Leukoc Biol       Date:  1995-06       Impact factor: 4.962

9.  Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4.

Authors:  J M Derocq; M Segui; C Poinot-Chazel; A Minty; D Caput; P Ferrara; P Casellas
Journal:  FEBS Lett       Date:  1994-04-18       Impact factor: 4.124

10.  An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.

Authors:  G Aversa; J Punnonen; B G Cocks; R de Waal Malefyt; F Vega; S M Zurawski; G Zurawski; J E de Vries
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  3 in total

1.  Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies.

Authors:  Shigeki Ohta; Yoko Ueda; Masae Yaguchi; Yumi Matsuzaki; Masaya Nakamura; Yoshiaki Toyama; Yoshikuni Tanioka; Norikazu Tamaoki; Tatsuji Nomura; Hideyuki Okano; Yutaka Kawakami; Masahiro Toda
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

2.  IgE promotes type 2 innate lymphoid cells in murine food allergy.

Authors:  O T Burton; J Medina Tamayo; A J Stranks; S Miller; K J Koleoglou; E O Weinberg; H C Oettgen
Journal:  Clin Exp Allergy       Date:  2018-01-22       Impact factor: 5.018

3.  Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.

Authors:  Hai-yan Hong; Hwa Young Lee; Wonjung Kwak; Jeongsoo Yoo; Moon-Hee Na; In Seop So; Tae-Hwan Kwon; Heon-Sik Park; Seung Huh; Goo Taeg Oh; Ick-Chan Kwon; In-San Kim; Byung-Heon Lee
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.